BEIJING, Oct. 17 (Xinhua) -- The following are the updates on the global fight against the COVID-19 pandemic.

- - - -

WELLINGTON -- New Zealand reported three new cases of COVID-19 on Saturday, said the Ministry of Health in a statement.

According to the ministry, all three cases were imported cases detected in managed isolation facilities. The first case arrived from Britain via Singapore on Oct. 9. The second and third imported cases arrived from the United Arab Emirates on Oct. 13.

- - - -

ABUJA -- A total of 181 students and teachers of a private high school in Lagos state, Nigeria's commercial hub, have tested positive for COVID-19, an official said Friday.

This followed surveillance and case investigation in the school located in Lekki, a city in Lagos, said Akin Abayomi, the state's commissioner for health.

- - - -

OTTAWA -- Canada's daily case counts continue to rise with an average of over 2,300 new cases being reported daily during the most recent seven days, according to the Public Health Agency of Canada on Friday.

Over the past week, there have been on average 870 individuals with COVID-19 in Canadian hospitals each day and 20 deaths reported daily, the agency added.

- - - -

BEIJING -- No new locally transmitted COVID-19 cases were reported Friday across the Chinese mainland, the National Health Commission said Saturday.

A total of 13 confirmed cases arriving from outside the mainland were reported, the commission said in its daily report.

- - - -

PARIS -- France confirmed 25,085 COVID-19 infections in the past 24 hours, pushing the total count since the epidemic outbreak in the country to 834,770, according to data released on Friday by health authorities.

The number of new infections was lower than a record 30,621 registered on Thursday. Still, it remained at a high level unseen during the first wave.

- - - -

ANKARA -- Turkey confirmed 1,812 new COVID-19 patients on Friday, raising the total diagnosed patients to 343,955.

Meanwhile, 73 people died in the past 24 hours, taking the death toll to 9,153, the Turkish Health Ministry announced.

- - - -

WASHINGTON -- The U.S. National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19, said a statement of the agency on Friday.

Some COVID-19 patients experience an immune response in which the immune system unleashes excessive amounts of proteins that trigger inflammation. The clinical trial aims to determine if modulating that immune response can reduce the need for ventilators and shorten hospital stays. Enditem

Related

Go to Forum >>0 Comment(s)